- Advertise
- Contact Us
- Contribute
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
- About Us
© 2021 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
Diabetes
The Endocrinology Network® Diabetes clinical resource center offers readers the very latest news and information related to diabetes management. Including content related to type 1 diabetes, type 2 diabetes, and gestational diabetes, the diabetes clinical resource center hosts information on FDA approvals, the latest studies, and practice updates for clinicians practicing in the field of endocrinology.
Race, Gender, & Income Influence Access to SGLT2 Inhibitors Among US Patients
April 15, 2021
Using data from nearly 1 million patients with type 2 diabetes in a commercial database, investigators provide a comprehensive of the impact race/ethnicity, gender, and income can have on the likelihood of receiving a prescription for SGLT2 inhibitors.
Low-Intensity Walking Program Fails to Show Benefit for Peripheral Artery Disease
April 14, 2021
A trial led by clinicians from Northwestern Medicine suggests the presence of ischemic leg symptoms could serve as a useful indicator for patients to help determine whether they will see a meaningful benefit from their walking program.
Stem Cells Show Promise for Nonhealing Diabetic Foot Ulcers in Phase 1 Trial
April 08, 2021
New data suggest injections of adipose-derived SVF cells could elicit wound closure in patients with nonhealing diabetic foot ulcers and, subsequently, reduce the need for amputation in this patient population.
Patients with Coronary Syndromes 3 Times More Likely to have Diabetes, More Susceptible to Adverse Outcomes
April 07, 2021
An analysis of the CLARIFY registry suggests patients with chronic coronary syndromes were 3 times more likely than the general population to have diabetes and these patients were at a greater risk of multiple adverse outcomes compared to their counterparts without diabetes.
Neuropathy Contributes, But Not Entirely Responsible for Fracture Risk in Type 1 Diabetes
April 07, 2021
A case-controlled study of 60 patients in the United Kingdom found presence neuropathy contributes to fracture risk in patients with type 1 diabetes but found other factors play a role in the increased risk among these patients.
High-Frequency Spinal Cord Stimulation Could Offer Hope in Refractory Diabetic Neuropathy
April 06, 2021
Results of a randomized clinical trial suggest treatment with high-frequency spinal cord stimulation added to conventional medical management could lead to pain relief and improvements in quality of life among patients with refractory peripheral diabetic neuropathy.
Dapagliflozin Effective as Heart Failure Treatment for Men and Women
April 05, 2021
An analysis of the DAPA-HF trial indicates the impact of dapagliflozin were consistent across both men and women receiving the SGLT2 inhibitor.
Anti-VEGF Treatments Prevent Progression of Diabetic Retinopathy, But Do Not Improve Vision
April 02, 2021
An analysis of 2-year data from the DRCR Retina Network's Protocol W study indicates anti-VEGF treatments can delay progression of NPDR to proliferative diabetic retinopathy but was not linked to improvements in visual acuity.
Daily Semaglutide Effective for Nonalcoholic Steatohepatitis in Phase 2 Trial
March 30, 2021
A phase 2 trial examining the effects of daily semaglutide over a 72-week period suggests the GLP1-RA could help patients with biopsy-confirmed nonalcoholic steatohepatitis (NASH) achieve NASH resolution.
NYHA Class Less Sensitive than KCCQ-OS for Capturing Heart Failure Progression
March 30, 2021
An analysis of the CHAMP-HF registry indicates KCCQ-OS was more sensitive at tracking changes in disease state among heart failure patients, indicating the importance of including patient-reported outcome measures in heart failure management.